Download Files:
RIPK1-IN-10
$580 – $5,600
Products Details
Product Description
– RIPK1-IN-10 is a potent RIPK1 inhibitor, example 37, extracted from patent WO2021160109[1].
Web ID
– HY-143728
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C30H28F2N6O4
References
– [1]ï‚·Zhou FuSheng, et al. Dihydronaphthyridinone compound, and preparation method therefor and medical use thereof. Patent WO2021160109.
CAS Number
– 2682889-51-4
Molecular Weight
– 574.58
Compound Purity
– 98.25
SMILES
– O=C(C1CC1)NC2=CN3N=C(C4=CC5=C(N=C4)CCN(CC6=CC(F)=CC(F)=C6OC7CCOCC7)C5=O)C=CC3=N2
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– DMSO : 31.25 mg/mL (ultrasonic;warming;heat to 70°C)
Target
– RIP kinase
Isoform
– RIPK1
Pathway
– Apoptosis
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
